All In MedTech

FDA Clearance Tracker · P170001

VIRTIS SACRAL NEUROMODULATION SYSTEM

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Jan 11, 2023 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Jan 11, 2023

Approved

Time to decision

2,185 days

Received Jan 17, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P170001
Device name
VIRTIS SACRAL NEUROMODULATION SYSTEM
Applicant location
Brooklyn Park, MN
Received
Jan 17, 2017
Decided
Jan 11, 2023
Decision
Approved

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code EZW

FDA's approval statement

As written in FDA's record.

Approval for the Virtis Sacral Neuromodulation System. This device is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code EZW. The earliest in FDA's data is P970004, decided Sep 29, 1997.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Cirtec Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.